AI-generated summary
The authors report a prospective, multi-center study of a new 1550 nm non-ablative resurfacing laser for acne scars in 47 subjects across Fitzpatrick skin types I to VI, treated with 1 to 6 sessions. They report that 78.0% were rated as improved on the GAIS scale, none worsened, and blinded scores improved significantly. The authors describe the treatment as well tolerated and conclude it is safe and effective, though the abstract's conclusions are not independently verified here.
- Participants
- 47
- Who or what was studied
- Adults with acne scars across Fitzpatrick skin types I to VI; mean age 40.2 years, 59.6% women.
- Wavelengths
- 1550 nm
- Limits stated in the abstract
- The abstract does not describe a control group, and the study's conclusions on safety and hyperpigmentation risk rest on the authors' own prospective, multi-center report.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Acne scars have traditionally been treated with non-ablative fractional resurfacing lasers. Traditional 1550 nm lasers can be limited in energy delivery, skin cooling, and safety across all skin types. A new-generation 1550 nm non-ablative resurfacing laser was recently developed, employing conical beams for high energy delivery through Focal Point Technology.
Objective
To evaluate the utility of a 1550 nm non-ablative resurfacing laser using Focal Point Technology to improve acne scars in Fitzpatrick skin types I-VI.
Methods And Materials
A prospective, multi-center clinical study investigated this novel resurfacing laser using 1-6 treatments.
Results
Forty-seven subjects with Fitzpatrick skin types I-VI were enrolled and treated. Mean age was 40.2 years, and 59.6% were women. Based on GAIS, 78.0% were rated as improved, with none worsening. Two of three blinded reviewers correctly identified photographs for 92.7% of subjects. Significant improvement in blinded ECCA score was observed (85.6 vs. 55.3; p < 0.0001), with 90.2% achieving at least a 15-point improvement. Treatments were well tolerated.
Conclusion
This new-generation 1550 nm non-ablative laser using Focal Point Technology with high energy delivery is safe and effective for acne scar treatment in all Fitzpatrick skin types. Its conical beams and cooling system significantly reduce hyperpigmentation risk in darker skin types.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1550 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.